Science Daily10h
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Medscape22h
Think the Urinary Tract Is Sterile? Think Again
Researchers confirm that bacteria naturally exist in the urinary tract, influencing kidney stone formation and potentially ...